GABA Administration Ameliorates Sjogren’s Syndrome in Two Different Mouse Models
Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by lymphocytic infiltrates in the salivary and lachrymal glands resulting in oral and ocular dryness. There are no clinically approved therapies to slow the progression of SS. Immune cells possess receptors for the neurotransmitte...
Main Authors: | Min Song, Jide Tian, Blake Middleton, Cuong Q. Nguyen, Daniel L. Kaufman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/1/129 |
Similar Items
-
GABA<sub>B</sub>-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice
by: Jide Tian, et al.
Published: (2021-01-01) -
GABA<sub>A</sub>-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice
by: Jide Tian, et al.
Published: (2021-05-01) -
The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19
by: Jide Tian, et al.
Published: (2023-01-01) -
Sjogren syndrome in the therapeutic practice (clinical case)
by: T.N. Belugina, et al.
Published: (2022-11-01) -
The GABA peceptors /
by: Enna, S. J., et al.
Published: (2007)